(Q43866031)

27 November 2017

Role of long-term nucleoside-analogue therapy in lipodystrophy and metabolic disorders in human immunodeficiency virus-infected patients (English)

1 reference

27 November 2017

1

Geneviève Chêne

1 reference

27 November 2017

13

Jean-Michel Molina

1 reference

27 November 2017

9

François Raffi

1 reference

27 November 2017

Emmanuelle Angelini

2

1 reference

27 November 2017

Laurent Cotte

3

1 reference

27 November 2017

Jean-Marie Lang

4

1 reference

27 November 2017

Philippe Morlat

5

1 reference

27 November 2017

Corinne Rancinan

6

1 reference

27 November 2017

Thierry May

7

1 reference

27 November 2017

Valérie Journot

8

1 reference

27 November 2017

Bernard Jarrousse

10

1 reference

27 November 2017

Michèle Grappin

11

1 reference

27 November 2017

Gérard Lepeu

12

1 reference

27 November 2017

language of work or name

English

0 references

publication date

24 January 2002

1 reference

Clinical Infectious Diseases

27 November 2017

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

27 November 2017

34

1 reference

27 November 2017

5

1 reference

27 November 2017

649-657

1 reference

"Buffalo hump" in men with HIV-1 infection.

27 November 2017

1 reference

Pseudo-Cushing's syndrome in human immunodeficiency virus-infected patients

21 January 2018

1 reference

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

21 January 2018

1 reference

Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy

21 January 2018

1 reference

A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy.

21 January 2018

1 reference

The ALBI trial: a randomized controlled trial comparing stavudine plus didanosine with zidovudine plus lamivudine and a regimen alternating both combinations in previously untreated patients infected with human immunodeficiency virus

21 January 2018

1 reference

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine Cohort, France, 1999. Groupe d'Epidémiologie Clinique du Syndrome d'Immunodéficience Acquise en Aquitaine

21 January 2018

1 reference

Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study.

21 January 2018

1 reference

Endocrine and metabolic evaluation of human immunodeficiency virus-infected patients with evidence of protease inhibitor-associated lipodystrophy

21 January 2018

1 reference

Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection

21 January 2018

1 reference

Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. Ritonavir/3TC/ZDV Study Group

21 January 2018

1 reference

Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors.

21 January 2018

1 reference

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance.

21 January 2018

1 reference

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy

21 January 2018

1 reference

Mitochondrial toxicity of antiviral drugs

21 January 2018

1 reference

A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/338811

1 reference

27 November 2017

1 reference